Together, these data implicated that susceptibility to colonic inflammation and inflammation-associated CRC in miR-146a−/− mice could be linked to enhanced IL-17 and IL-17-promoting cytokines by myeloid cells. This evidence concerns the gene IL17A and colorectal carcinoma.